Association of LOX-1 gene polymorphisms with cerebral infarction in northern Chinese Han population

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Liu, Xu ^a   Zhu, Rui Xia ^a   Li, Lei ^a   He, Zhi Yi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Cerebral infarction; LOX 1; Ox LDL; Polymorphisms

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; BRAIN INFARCTION; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; AGED; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCAVENGER RECEPTORS, CLASS E; SEQUENCE ANALYSIS, DNA;

EID: 84899461630     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-55     Document Type: Article

References (25)

1. Stroke. Donnan GA, Fisher M, Macleod M, Davis SM, Lancet 2008 371 1612 1623
2. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Liu L, Wang D, Wong KS, Wang Y, Stroke 2011 42 3651 3654
3. Is there a stroke belt in China and why? Xu G, Ma M, Liu X, Hankey GJ, Stroke 2013 44 1775 1783
4. Stroke in China: epidemiology, prevention, and management strategies. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ, Lancet Neurol 2007 6 456 464
5. Genetic susceptibility to ischemic stroke. Meschia JF, Worrall BB, Rich SS, Nat Rev Neurol 2011 7 369 378
6. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Flossmann E, Schulz UG, Rothwell PM, Stroke 2004 35 212 227
7. An endothelial receptor for oxidized low-density lipoprotein. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T, Nature 1997 386 73 77
8. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G, Cardiovasc Res 2006 69 36 45
9. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P, Cell Mol Life Sci 2013 70 2859 2872
10. The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Yamanaka S, Zhang XY, Miura K, Kim S, Iwao H, Genomics 1998 54 191 199
11. Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. Mango R, Clementi F, Borgiani P, Forleo GB, Federici M, Contino G, Giardina E, Garza L, Fahdi IE, Lauro R, Mehta JL, Novelli G, Romeo F, J Med Genet 2003 40 933 936
12. Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction. Novelli G, Borgiani P, Mango R, Lauro R, Romeo F, Nutr Metab Cardiovasc Dis 2007 17 7 8 author reply e9-10
13. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Chen Q, Reis SE, Kammerer C, Craig WY, LaPierre SE, Zimmer EL, McNamara DM, Pauly DF, Sharaf B, Holubkov R, Bairey Merz CN, Sopko G, Bontempo F, Kamboh MI, Circulation 2003 107 3146 3151
14. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Tatsuguchi M, Furutani M, Hinagata J, Tanaka T, Furutani Y, Imamura S, Kawana M, Masaki T, Kasanuki H, Sawamura T, Matsuoka R, Biochem Biophys Res Commun 2003 303 247 250
15. A candidate gene study revealed sex-specific association between the OLR1 gene and carotid plaque. Wang L, Yanuck D, Beecham A, Gardener H, Slifer S, Blanton SH, Sacco RL, Rundek T, Stroke 2011 42 588 592
16. IVS4-14 A/G and IVS4-73C/T polymorphisms in OLR1 gene in patients with ischemic cerebrovascular diseases. Vietri MT, Molinari AM, Boggia M, Parisi M, Cioffi M, Genet Test Mol Biomarkers 2010 14 9 11
17. G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Hattori H, Sonoda A, Sato H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N, Brain Res 2006 1121 246 249
18. On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Trabetti E, Biscuola M, Cavallari U, Malerba G, Girelli D, Olivieri O, Martinelli N, Corrocher R, Pignatti PF, Eur J Hum Genet 2006 14 127 130
19. The 3'-UTR C > T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease. Sentinelli F, Filippi E, Fallarino M, Romeo S, Fanelli M, Buzzetti R, Berni A, Baroni MG, Nutr Metab Cardiovasc Dis 2006 16 345 352
20. Is LOX-1 K167N polymorphism protective for coronary artery disease? Kurnaz O, Aydogan HY, Isbir CS, Tekeli A, Isbir T, In Vivo 2009 23 969 973
21. 3'UTR/T polymorphism of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is associated with modified anti-platelet activity of atorvastatin in hypercholesterolemic subjects. Puccetti L, Pasqui AL, Pastorelli M, Ciani F, Palazzuoli A, Gioffre W, Auteri A, Bruni F, Atherosclerosis 2005 183 322 328
22. Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. Biocca S, Falconi M, Filesi I, Baldini F, Vecchione L, Mango R, Romeo F, Federici G, Desideri A, Novelli G, PLoS One 2009 4 4648
23. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd, Stroke 1993 24 35 41
24. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors. Khanna M, Park P, Zirvi M, Cao W, Picon A, Day J, Paty P, Barany F, Oncogene 1999 18 27 38
25. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Rodriguez S, Gaunt TR, Day IN, Am J Epidemiol 2009 169 505 514